E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/7/2007 in the Prospect News PIPE Daily.

New Issue: DNA Sciences to raise $2 million in bridge financing

By LLuvia Mares

New York, Sept. 7 - Applied DNA Sciences, Inc. intends to raise up to $2 million in bridge financing and up to $9 million in a follow-on financing through the issuance of convertible notes and warrants.

The bridge loan will be for no more than $2 million with a one-year maturity bearing interest at 10% per annum with 4 million four-year warrants exercisable at $0.50 per share.

The $2 million bridge loan will be convertible up to the first anniversary of issuance into shares of the company's common stock at a price equal to 50% of the average closing price for the 10 days prior to the conversion notice date.

There is an automatic conversion provision at a price equal to a 30% discount to the average volume weighted average price of the common stock for the 10 trading days prior to the closing date of the loan.

The offering for the $9 million will consist of 10% senior secured convertible notes with 18 million four-year warrants exercisable at $0.50 per share. The notes will have a two-year term.

The notes are convertible into shares of common stock at a price equal to 50% of the average closing price of the 10 days prior to the conversion notice with a conversion price equal to a 20% discount to the average volume weighted average price of the common stock for the ten trading days prior to the closing date of the offering.

Arjent Ltd. acted as placement agent in the transaction.

Stony Brook, N.Y.-based DNA Sciences provides patented DNA-based technologies to prevent and identify counterfeits.

Issuer: Applied DNA Sciences, Inc.

Issue: Convertible notes and warrants

Amount: $2 million bridge financing and up to $9 million in a follow-on financing

Maturity: One-year for bridge financing and two-years for follow-on

Coupon:10%
Conversion price: 30% discount to the average volume weighted average price of the common stock for the ten trading days prior to the conversion notice date.
Placement agent: Arjent Ltd.
Announcement date: Sept. 7
Stock symbol: OTCBB: APDN
Stock price: $0.12 at close Sept. 6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.